Mechanisms of antibiotic resistance in enterococci

References

• Murray BE. The life and times of the Enterococcus. Clin Microbiol Rev 1990;3:46-65
   PubMed Web of Science ®Google Scholar
• Hidron AI, Edwards JR, Patel J, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008;29:996-1011
   PubMed Web of Science ®Google Scholar
• Williamson R, Calderwood SB, Moellering RC, et al. Studies on the mechanism of intrinsic resistance to beta-lactam antibiotics in group D streptococci. J Gen Microbiol 1983;129:813-22
   PubMedGoogle Scholar
• Schatz A and Waksman S. Effect of streptomycin and other antibiotic substances upon Mycobacterium tuberculosis and related organisms. Proc Soc Exp Biol Med 1944;57:244-8
   Google Scholar
• Robbins WC and Tompsett R. Treatment of enterococcal endocarditis and bacteremia; results of combined therapy with penicillin and streptomycin. Am J Med 1951;10:278-99
   PubMedGoogle Scholar
• Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005;111:e394-434
   PubMed Web of Science ®Google Scholar
• Lebreton F, van Schaik W, McGuire AM, et al. Emergence of Epidemic Multidrug-Resistant Enterococcus faecium from Animal and Commensal Strains. MBio 2013;4:e00534-13
   Google Scholar
• Arias CA, Murray BE. The rise of the Enterococcus: beyond vancomycin resistance. Nat Rev Microbiol 2012;10:266-78
   PubMed Web of Science ®Google Scholar
• Chang S, Sievert D, Hageman J, et al. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med 2003;348:1342-7
   PubMed Web of Science ®Google Scholar
• Ray A, Pultz N, Bhalla A, et al. Coexistence of vancomycin-resistant enterococci and Staphylococcus aureus in the intestinal tracts of hospitalized patients. Clin Infect Dis 2003;37:875-81
   PubMedGoogle Scholar
• Williamson R, Gutmann L, Horaud T, et al. Use of Penicillin-binding Proteins for the identification of enterococci. J Gen Microbiol 1986;132:1929-37
   PubMedGoogle Scholar
• Duez C, Hallut S, Rhazi N, et al. The ponA gene of Enterococcus faecalis JH2-2 codes for a low-affinity class A penicillin-binding protein. J Bacteriol 2004;186:4412-16
   PubMedGoogle Scholar
• Signoretto C, Boaretti M and Canepari P. Cloning, sequencing and expression in Escherichia coli of the low-affinity penicillin binding protein of Enterococcus faecalis. FEMS Microbiol Lett 1994;123:99-106
   PubMedGoogle Scholar
• Sifaoui F, Arthur M, Rice L, et al. Role of Penicillin-Binding Protein 5 in Expression of Ampicillin Resistance and Peptidoglycan Structure in Enterococcus faecium. Antimicrob Agents Chemother 2001;45:2594-7
   PubMed Web of Science ®Google Scholar
• Rice LB, Carias LL, Hutton-Thomas R, et al. Penicillin-Binding Protein 5 and Expression of Ampicillin Resistance in Enterococcus faecium. Antimicrob Agents Chemother 2001;45:1480-6
   PubMed Web of Science ®Google Scholar
• Fontana R, Aldegheri M, Ligozzi M, et al. Overproduction of a low-affinity penicillin-binding protein and high-level ampicillin resistance in Enterococcus faecium. Antimicrob Agents Chemother 1994;38:1980-3
   PubMed Web of Science ®Google Scholar
• Rice LB, Bellais S, Carias LL, et al. Impact of Specific pbp5 Mutations on Expression of Beta-Lactam Resistance in Enterococcus faecium. Antimicrob Agents Chemother 2004;48:3028-32
   PubMed Web of Science ®Google Scholar
• Galloway-Peña JR, Rice LB, Murray BE. Analysis of PBP5 of early U.S. isolates of Enterococcus faecium: sequence variation alone does not explain increasing ampicillin resistance over time. Antimicrob Agents Chemother 2011;55:3272-7
   PubMedGoogle Scholar
• Duez C, Zorzi W, Sapunaric F, et al. The penicillin resistance of Enterococcus faecalis JH2-2r results from an overproduction of the low-affinity penicillin-binding protein PBP4 and does not involve a psr-like gene. Microbiology 2001;147:2561-9
   PubMedGoogle Scholar
• Ono S, Muratani T, Matsumoto T. Mechanisms of Resistance to Imipenem and Ampicillin in Enterococcus faecalis. Antimicrob Agents Chemother 2005;49:2954-8
   Google Scholar
• Murray BE. Beta-lactamase-producing enterococci. Antimicrob Agents Chemother 1992;36:2355-9
   PubMed Web of Science ®Google Scholar
• Coudron PE, Markowitz SM, Wong ES. Isolation of a betalactamase-producing, aminoglycoside-resistant strain of Enterococcus faecium. Antimicrob Agents Chemother 1992;36:1125-6
   PubMedGoogle Scholar
• Hackbarth CJ, Chambers HF. blaI and blaR1 regulate beta-lactamase and PBP 2a production in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1993;37:1144-9
   PubMed Web of Science ®Google Scholar
• Sarti M, Campanile F, Sabia C, et al. Polyclonal diffusion of beta-lactamase-producing Enterococcus faecium. J Clin Microbiol 2012;50:169-72
   PubMedGoogle Scholar
• Mainardi JL, Legrand R, Arthur M, et al. Novel mechanism of beta-lactam resistance due to bypass of DD-transpeptidation in Enterococcus faecium. J Biol Chem 2000;275:16490-6
   PubMedGoogle Scholar
• Sacco E, Hugonnet JE, Josseaume N, et al. Activation of the L,D-transpeptidation peptidoglycan cross-linking pathway by a metallo-D,D-carboxypeptidase in Enterococcus faecium. Mol Microbiol 2010;75:874-85
   PubMedGoogle Scholar
• Cremniter J, Mainardi JL, Josseaume N, et al. Novel mechanism of resistance to glycopeptide antibiotics in Enterococcus faecium. J Biol Chem 2006;281:32254-62
   PubMedGoogle Scholar
• Rice LB, Carias LL, Rudin S, et al. Role of class A penicillin-binding proteins in the expression of beta-lactam resistance in Enterococcus faecium. J Bacteriol 2009;191:3649-56
   PubMed Web of Science ®Google Scholar
• Arbeloa A, Segal H, Hugonnet JE, et al. Role of class A penicillin-binding proteins in PBP5-mediated beta-lactam resistance in Enterococcus faecalis. J Bacteriol 2004;186:1221-8
   PubMed Web of Science ®Google Scholar
• Hancock LE, Perego M. Systematic inactivation and phenotypic characterization of two-component signal transduction systems of Enterococcus faecalis V583. J Bacteriol 2004;186:7951-8
   PubMedGoogle Scholar
• Comenge Y, Quintiliani R Jr, Li L, et al. The CroRS two-component regulatory system is required for intrinsic beta-lactam resistance in Enterococcus faecalis. J Bacteriol 2003;185:7184-92
   PubMedGoogle Scholar
• Le Breton Y, Muller C, Auffray Y, et al. New insights into the Enterococcus faecalis CroRS two-component system obtained using a differential-display random arbitrarily primed PCR approach. Appl Environ Microbiol 2007;73:3738-41
   PubMedGoogle Scholar
• Muller C, Le Breton Y, Morin T, et al. The response regulator CroR modulates expression of the secreted stress-induced SalB protein in Enterococcus faecalis. J Bacteriol 2006;188:2636-45
   PubMedGoogle Scholar
• Kristich CJ, Wells CL, Dunny GM. A eukaryotic-type Ser/Thr kinase in Enterococcus faecalis mediates antimicrobial resistance and intestinal persistence. Proc Natl Acad Sci USA 2007;104:3508-13
   PubMedGoogle Scholar
• Kristich CJ, Little JL, Hall CL, et al. Reciprocal regulation of cephalosporin resistance in Enterococcus faecalis. MBio 2011;2:e00199-11
   Google Scholar
• Hall CL, Tschannen M, Worthey EA, et al. IreB, a Ser/Thr kinase substrate, influences antimicrobial resistance in Enterococcus faecalis. Antimicrob Agents Chemother 2013;57:6179-86
   PubMedGoogle Scholar
• Vesić D, Kristich CJ. MurAA is required for intrinsic cephalosporin resistance of Enterococcus faecalis. Antimicrob Agents Chemother 2012;56:2443-51
   PubMedGoogle Scholar
• Courvalin P. Vancomycin resistance in gram-positive cocci. Clin Infect Dis 2006;42:S25-34
   PubMed Web of Science ®Google Scholar
• Guardabassi L, Agersø Y. Genes homologous to glycopeptide resistance vanA are widespread in soil microbial communities. FEMS Microbiol Lett 2006;259:221-5
   Google Scholar
• Boyd DA, Willey BM, Fawcett D, et al. Molecular characterization of Enterococcus faecalis N06-0364 with low-level vancomycin resistance harboring a novel D-Ala-D-Ser gene cluster, vanL. Antimicrob Agents Chemother 2008;52:2667-72
   PubMed Web of Science ®Google Scholar
• Xu X, Lin D, Yan G, et al. vanM, a new glycopeptide resistance gene cluster found in Enterococcus faecium. Antimicrob Agents Chemother 2010;54:4643-7
   PubMed Web of Science ®Google Scholar
• Lebreton F, Depardieu F, Bourdon N, et al. D-Ala-d-Ser VanN-type transferable vancomycin resistance in Enterococcus faecium. Antimicrob Agents Chemother 2011;55:4606-12
   PubMed Web of Science ®Google Scholar
• Depardieu F, Podglajen I, Leclercq R, et al. Modes and modulations of antibiotic resistance gene expression. Clin Microbiol Rev 2007;20:79-114
   PubMed Web of Science ®Google Scholar
• Arthur M, Depardieu F, Molinas C, et al. The vanZ gene of Tn1546 from Enterococcus faecium BM4147 confers resistance to teicoplanin. Gene 1995;154:87-92
   PubMedGoogle Scholar
• Baptista M, Depardieu F, Reynolds P, et al. Mutations leading to increased levels of resistance to glycopeptide antibiotics in VanB-type enterococci. Mol Microbiol 1997;25:93-105
   PubMedGoogle Scholar
• Arias CA, Courvalin P, Reynolds PE. vanC cluster of vancomycin-resistant Enterococcus gallinarum BM4174. Antimicrob Agents Chemother 2000;44:1660-6
   PubMed Web of Science ®Google Scholar
• Arias CA, Martín-Martinez M, Blundell TL, et al. Characterization and modelling of VanT: a novel, membrane-bound, serine racemase from vancomycin-resistant Enterococcus gallinarum BM4174. Mol Microbiol 1999;31:1653-64
   PubMedGoogle Scholar
• Fines M, Perichon B, Reynolds P, et al. VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405. Antimicrob Agents Chemother 1999;43:2161-4
   PubMed Web of Science ®Google Scholar
• Abadía Patiño L, Courvalin P, Perichon B. vanE gene cluster of vancomycin-resistant Enterococcus faecalis BM4405. J Bacteriol 2002;184:6457-64
   PubMedGoogle Scholar
• Depardieu F, Kolbert M, Pruul H, et al. VanD-type vancomycin-resistant Enterococcus faecium and Enterococcus faecalis. Antimicrob Agents Chemother 2004;48:3892-904
   PubMedGoogle Scholar
• Yowler CJ, Blinkhorn RJ, Fratianne RB. Vancomycin-dependent enterococcal strains: case report and review. J Trauma 2000;48:783-5
   PubMedGoogle Scholar
• San Millan A, Depardieu F, Godreuil S, et al. VanB-type Enterococcus faecium clinical isolate successively inducibly resistant to, dependent on, and constitutively resistant to vancomycin. Antimicrob Agents Chemother 2009;53:1974-82
   PubMedGoogle Scholar
• Steenbergen JN, Alder J, Thorne GM, et al. Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections. J Antimicrob Chemother 2005;55:283-8
   PubMed Web of Science ®Google Scholar
• Muraih JK, Harris J, Taylor SD, et al. Characterization of daptomycin oligomerization with perylene excimer fluorescence: stoichiometric binding of phosphatidylglycerol triggers oligomer formation. Biochim Biophys Acta 2012;1818:673-8
   PubMedGoogle Scholar
• Zhang T, Muraih JK, Tishbi N, et al. Cardiolipin prevents membrane translocation and permeabilization by daptomycin. J Biol Chem 2014;289:11584-91
   PubMed Web of Science ®Google Scholar
• Pogliano J, Pogliano N, Silverman JA. Daptomycin-mediated reorganization of membrane architecture causes mislocalization of essential cell division proteins. J Bacteriol 2012;194:4494-504
   PubMed Web of Science ®Google Scholar
• Cantón R, Ruiz-Garbajosa P, Chaves R, et al. A potential role for daptomycin in enterococcal infections: what is the evidence? J Antimicrob Chemother 2010;65:1126-36
   PubMed Web of Science ®Google Scholar
• Arias CA, Panesso D, McGrath DM, et al. Genetic basis for in vivo daptomycin resistance in enterococci. N Engl J Med 2011;365:892-900
   PubMed Web of Science ®Google Scholar
• Jordan S, Junker A, Helmann JD, et al. Regulation of LiaRS-dependent gene expression in bacillus subtilis: identification of inhibitor proteins, regulator binding sites, and target genes of a conserved cell envelope stress-sensing two-component system. J Bacteriol 2006;188:5153-66
   PubMed Web of Science ®Google Scholar
• Munita JM, Tran TT, Diaz L, et al. A liaF codon deletion abolishes daptomycin bactericidal activity against vancomycin-resistant Enterococcus faecalis. Antimicrob Agents Chemother 2013;57:2831-3
   PubMed Web of Science ®Google Scholar
• Palmer KL, Daniel A, Hardy C, et al. Genetic basis for daptomycin resistance in enterococci. Antimicrob Agents Chemother 2011;55:3345-56
   PubMedGoogle Scholar
• Jones T, Yeaman MR, Sakoulas G, et al. Failures in clinical treatment of Staphylococcus aureus Infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding. Antimicrob Agents Chemother 2008;52:269-78
   PubMed Web of Science ®Google Scholar
• Tran TT, Panesso D, Mishra NN, et al. Daptomycin-resistant Enterococcus faecalis diverts the antibiotic molecule from the division septum and remodels cell membrane phospholipids. MBio 2013;4:13
   Google Scholar
• Miller C, Kong J, Tran TT, et al. Adaptation of enterococcus faecalis to daptomycin reveals an ordered progression to resistance. Antimicrob Agents Chemother 2013;57:5373-83
   PubMedGoogle Scholar
• Tran TT, Panesso D, Gao H, et al. Whole-genome analysis of a daptomycin-susceptible Enterococcus faecium strain and its daptomycin-resistant variant arising during therapy. Antimicrob Agents Chemother 2013;57(1):261-8
   PubMedGoogle Scholar
• Dubrac S, Bisicchia P, Devine KM, et al. A matter of life and death: cell wall homeostasis and the WalKR (YycGF) essential signal transduction pathway. Mol Microbiol 2008;70:1307-22
   PubMed Web of Science ®Google Scholar
• Mishra NN, Bayer AS, Tran TT, et al. Daptomycin resistance in enterococci is associated with distinct alterations of cell membrane phospholipid content. PLoS One 2012;7:e43958
   PubMed Web of Science ®Google Scholar
• Diaz L, Tran TT, Munita JM, et al. Whole-Genome Analyses of Enterococcus faecium Isolates with Diverse Daptomycin MICs. Antimicrob Agents Chemother 2014;58:4527-34
   PubMed Web of Science ®Google Scholar
• Munita J, Panesso D, Diaz L, et al. Correlation between mutations in liaFSR of Enterococcus faecium and MIC of daptomycin: revisiting daptomycin breakpoints. Antimicrob Agents Chemother 2012;56:4354-9
   PubMed Web of Science ®Google Scholar
• Munita JM, Mishra NN, Alvarez D, et al. Failure of High-Dose Daptomycin for Bacteremia Caused by Daptomycin Susceptible Enterococcus faecium Harboring LiaSR Substitutions. Clin Infect Dis 2014. [Epub ahead of print]
   PubMedGoogle Scholar
• Sakoulas G, Bayer AS, Pogliano J, et al. Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother 2012;56:838-44
   PubMed Web of Science ®Google Scholar
• Hall Snyder A, Werth BJ, Barber KE, et al. Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model. J Antimicrob Chemother 2014;69(8):2148-54
   PubMed Web of Science ®Google Scholar
• Sakoulas G, Rose W, Nonejuie P, et al. Ceftaroline restores daptomycin activity against daptomycin-nonsusceptible vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother 2014;58:1494-500
   PubMed Web of Science ®Google Scholar
• Costa Y, Galimand M, Leclercq R, et al. Characterization of the chromosomal aac(6’)-Ii gene specific for Enterococcus faecium. Antimicrob Agents Chemother 1993;37:1896-903
   PubMed Web of Science ®Google Scholar
• Galimand M, Schmitt E, Panvert M, et al. Intrinsic resistance to aminoglycosides in Enterococcus faecium is conferred by the 16S rRNA m5C1404-specific methyltransferase EfmM. RNA 2011;17:251-62
   PubMedGoogle Scholar
• Eliopoulos GM, Farber BF, Murray BE, et al. Ribosomal resistance of clinical enterococcal to streptomycin isolates. Antimicrob Agents Chemother 1984;25:398-9
   PubMed Web of Science ®Google Scholar
• Krogstad D, Korfhagen T, Moellering R, et al. Aminoglycoside-inactivating enzymes in clinical isolates of Streptococcus faecalis. An explanation for resistance to antibiotic synergism. J Clin Invest 1978;62:480-6
   PubMed Web of Science ®Google Scholar
• Courvalin P, Carlier C, Collatz E. Plasmid-mediated resistance to aminocyclitol antibiotics in group D streptococci. J Bacteriol 1980;143:541-51
   PubMed Web of Science ®Google Scholar
• Chow J, Zervos M, Lerner S, et al. A novel gentamicin resistance gene in Enterococcus. Antimicrob Agents Chemother 1997;41:511-14
   PubMedGoogle Scholar
• Tsai S, Zervos M, Clewell D, et al. A new high-level gentamicin resistance gene, aph(2’’)-Id, in Enterococcus spp. Antimicrob Agents Chemother 1998;42:1229-32
   PubMedGoogle Scholar
• Chow J. Aminoglycoside resistance in enterococci. Clin Infect Dis 2000;31:586-9
   PubMed Web of Science ®Google Scholar
• Shinabarger D, Marotti K, Murray R, et al. Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactions. Antimicrob Agents Chemother 1997;41:2132-6
   PubMed Web of Science ®Google Scholar
• Leach K, Swaney S, Colca J, et al. The site of action of oxazolidinone antibiotics in living bacteria and in human mitochondria. Mol Cell 2007;26:393-402
   PubMed Web of Science ®Google Scholar
• Marshall S, Donskey C, Hutton-Thomas R, et al. Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis. Antimicrob Agents Chemother 2002;46:3334-6
   PubMed Web of Science ®Google Scholar
• Boumghar-Bourtchaï L, Dhalluin A, Malbruny B, et al. Influence of recombination on development of mutational resistance to linezolid in Enterococcus faecalis JH2-2. Antimicrob Agents Chemother 2009;53:4007-9
   PubMedGoogle Scholar
• Bourgeois-Nicolaos N, Massias L, Couson B, et al. Dose dependence of emergence of resistance to linezolid in Enterococcus faecalis in vivo. J Infect Dis 2007;195:1480-8
   PubMed Web of Science ®Google Scholar
• Locke JB, Hilgers M, Shaw KJ. Mutations in ribosomal protein L3 are associated with oxazolidinone resistance in staphylococci of clinical origin. Antimicrob Agents Chemother 2009;53:5275-8
   PubMed Web of Science ®Google Scholar
• Chen H, Wu W, Ni M, et al. Linezolid-resistant clinical isolates of enterococci and Staphylococcus cohnii from a multicentre study in China: molecular epidemiology and resistance mechanisms. Int J Antimicrob Agents 2013;42:317-21
   PubMed Web of Science ®Google Scholar
• Toh S, Xiong L, Arias C, et al. Acquisition of a natural resistance gene renders a clinical strain of methicillin-resistant Staphylococcus aureus resistant to the synthetic antibiotic linezolid. Mol Microbiol 2007;64:1506-14
   PubMed Web of Science ®Google Scholar
• Mendes R, Deshpande L, Castanheira M, et al. First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States. Antimicrob Agents Chemother 2008;52:2244-6
   PubMed Web of Science ®Google Scholar
• Diaz L, Kiratisin P, Mendes R, et al. Transferable plasmid-mediated resistance to linezolid due to cfr in a human clinical isolate of Enterococcus faecalis. Antimicrob Agents Chemother 2012;56:3917-22
   PubMed Web of Science ®Google Scholar
• Hennig S and Ziebuhr W. Characterization of the transposase encoded by IS256, the prototype of a major family of bacterial insertion sequence elements. J Bacteriol 2010;192:4153-63
   PubMedGoogle Scholar
• Diaz L, Kontoyiannis DP, Panesso D, et al. Dissecting the mechanisms of linezolid resistance in a Drosophila melanogaster infection model of Staphylococcus aureus. J Infect Dis 2013;208:83-91
   PubMed Web of Science ®Google Scholar
• Singh K, Weinstock G, Murray B. An Enterococcus faecalis ABC homologue (Lsa) is required for the resistance of this species to clindamycin and quinupristin-dalfopristin. Antimicrob Agents Chemother 2002;46:1845-50
   PubMed Web of Science ®Google Scholar
• Hershberger E, Donabedian S, Konstantinou K, et al. Quinupristin-dalfopristin resistance in gram-positive bacteria: mechanism of resistance and epidemiology. Clin Infect Dis 2004;38:92-8
   PubMed Web of Science ®Google Scholar
• Portillo A, Ruiz-Larrea F, Zarazaga M, et al. Macrolide resistance genes in Enterococcus spp. Antimicrob Agents Chemother 2000;44:967-71
   PubMed Web of Science ®Google Scholar
• Weisblum B. Erythromycin resistance by ribosome modification. Antimicrob Agents Chemother 1995;39:577-85
   PubMed Web of Science ®Google Scholar
• Canu A, Leclercq R. Overcoming bacterial resistance by dual target inhibition: the case of streptogramins. Curr Drug Targets Infect Disord 2001;1:215-25
   PubMedGoogle Scholar
• Werner G, Klare I, Witte W. Molecular analysis of streptogramin resistance in enterococci. Int J Med Microbiol 2002;292:81-94
   PubMed Web of Science ®Google Scholar
• Korczynska M, Mukhtar T, Wright G, et al. Structural basis for streptogramin B resistance in Staphylococcus aureus by virginiamycin B lyase. Proc Natl Acad Sci USA 2007;104:10388-93
   PubMedGoogle Scholar
• Fantin B, Leclercq R, Garry L, et al. Influence of inducible cross-resistance to macrolides, lincosamides, and streptogramin B-type antibiotics in Enterococcus faecium on activity of quinupristin-dalfopristin in vitro and in rabbits with experimental endocarditis. Antimicrob Agents Chemother 1997;41:931-5
   PubMed Web of Science ®Google Scholar
• Isnard C, Malbruny B, Leclercq R, et al. Genetic basis for in vitro and in vivo resistance to lincosamides, streptogramins A, and pleuromutilins (LSAP phenotype) in Enterococcus faecium. Antimicrob Agents Chemother 2013;57:4463-9
   PubMed Web of Science ®Google Scholar
• Schnappinger D, Hillen W. Tetracyclines: antibiotic action, uptake, and resistance mechanisms. Arch Microbiol 1996;165:359-69
   PubMed Web of Science ®Google Scholar
• Chopra I and Roberts M. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev 2001;65:232-60
   PubMedGoogle Scholar
• Schwarz S, Cardoso M, Wegener HC. Nucleotide sequence and phylogeny of the tet(L) tetracycline resistance determinant encoded by plasmid pSTE1 from Staphylococcus hyicus. Antimicrob Agents Chemother 1992;36:580-8
   PubMed Web of Science ®Google Scholar
• Pepper K, Horaud T, Le Bouguénec C, et al. Location of antibiotic resistance markers in clinical isolates of Enterococcus faecalis with similar antibiotypes. Antimicrob Agents Chemother 1987;31:1394-402
   PubMedGoogle Scholar
• Bentorcha F, De Cespédès G, Horaud T. Tetracycline resistance heterogeneity in Enterococcus faecium. Antimicrob Agents Chemother 1991;35:808-12
   PubMedGoogle Scholar
• Bauer G, Berens C, Projan S, et al. Comparison of tetracycline and tigecycline binding to ribosomes mapped by dimethylsulphate and drug-directed Fe2+ cleavage of 16S rRNA. J Antimicrob Chemother 2004;53:592-9
   PubMed Web of Science ®Google Scholar
• Fluit A, Florijn A, Verhoef J, et al. Presence of tetracycline resistance determinants and susceptibility to tigecycline and minocycline. Antimicrob Agents Chemother 2005;49:1636-8
   PubMed Web of Science ®Google Scholar
• Werner G, Gfrörer S, Fleige C, et al. Tigecycline-resistant Enterococcus faecalis strain isolated from a German intensive care unit patient. J Antimicrob Chemother 2008;61:1182-3
   PubMedGoogle Scholar
• Cordina C, Hill R, Deshpande A, et al. Tigecycline-resistant Enterococcus faecalis associated with omeprazole use in a surgical patient. J Antimicrob Chemother 2012;67:1806-7
   Google Scholar
• Hawkey P. Mechanisms of quinolone action and microbial response. J Antimicrob Chemother 2003;51 Suppl 1:29-35
   PubMedGoogle Scholar
• Oyamada Y, Ito H, Fujimoto K, et al. Combination of known and unknown mechanisms confers high-level resistance to fluoroquinolones in Enterococcus faecium. J Med Microbiol 2006;55:729-36
   PubMed Web of Science ®Google Scholar
• López M, Tenorio C, Del Campo R, et al. Characterization of the mechanisms of fluoroquinolone resistance in vancomycin-resistant enterococci of different origins. J Chemother 2011;23:87-91
   PubMed Web of Science ®Google Scholar
• Werner G, Fleige C, Ewert B, et al. High-level ciprofloxacin resistance among hospital-adapted Enterococcus faecium (CC17). Int J Antimicrob Agents 2010;35:119-25
   PubMed Web of Science ®Google Scholar
• Yasufuku T, Shigemura K, Shirakawa T, et al. Mechanisms of and risk factors for fluoroquinolone resistance in clinical Enterococcus faecalis isolates from patients with urinary tract infections. J Clin Microbiol 2011;49:3912-16
   PubMedGoogle Scholar
• Hooper D. Mechanisms of action and resistance of older and newer fluoroquinolones. Clin Infect Dis 2000;31(Suppl 2):S24-8
   PubMed Web of Science ®Google Scholar
• Arsène S, Leclercq R. Role of a qnr-like gene in the intrinsic resistance of Enterococcus faecalis to fluoroquinolones. Antimicrob Agents Chemother 2007;51:3254-8
   PubMed Web of Science ®Google Scholar
• Tran J, Jacoby G, Hooper D. Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase. Antimicrob Agents Chemother 2005;49:118-25
   PubMed Web of Science ®Google Scholar
• Deshpande L, Fritsche T, Moet G, et al. Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis 2007;58:163-70
   PubMed Web of Science ®Google Scholar
• Kristich C, Little J. Mutations in the β subunit of RNA polymerase alter intrinsic cephalosporin resistance in Enterococci. Antimicrob Agents Chemother 2012;56:2022-7
   PubMedGoogle Scholar
• Enne V, Delsol A, Roe J, et al. Rifampicin resistance and its fitness cost in Enterococcus faecium. J Antimicrob Chemother 2004;53:203-7
   PubMed Web of Science ®Google Scholar
• Rand K, Houck H, Silverman J, et al. Daptomycin-reversible rifampicin resistance in vancomycin-resistant Enterococcus faecium. J Antimicrob Chemother 2007;59:1017-20
   PubMedGoogle Scholar
• Chenoweth C, Robinson K, Schaberg D. Efficacy of ampicillin versus trimethoprim-sulfamethoxazole in a mouse model of lethal enterococcal peritonitis. Antimicrob Agents Chemother 1990;34:1800-2
   Google Scholar
• Grayson M, Thauvin-Eliopoulos C, Eliopoulos G, et al. Failure of trimethoprim-sulfamethoxazole therapy in experimental enterococcal endocarditis. Antimicrob Agents Chemother 1990;34:1792-4
   Google Scholar
• Otto M. Bacterial evasion of antimicrobial peptides by biofilm formation. Curr Top Microbiol Immunol 2006;306:251-8
   PubMed Web of Science ®Google Scholar
• Peschel A, Sahl H. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat Rev Microbiol 2006;4:529-36
   PubMed Web of Science ®Google Scholar
• Kandaswamy K, Liew T, Wang C, et al. Focal targeting by human β-defensin 2 disrupts localized virulence factor assembly sites in Enterococcus faecalis. Proc Natl Acad Sci USA 2013;110:20230-5
   PubMedGoogle Scholar
• Gilmore M, Lebreton F, Van Tyne D. Dual defensin strategy for targeting Enterococcus faecalis. Proc Natl Acad Sci USA 2013;110:19980-1
   PubMedGoogle Scholar
• Theilacker C, Kaczyński Z, Kropec A, et al. Serodiversity of opsonic antibodies against Enterococcus faecalis – glycans of the cell wall revisited. PLoS One 2011;6:e17839
   PubMedGoogle Scholar
• Theilacker C, Kaczynski Z, Kropec A, et al. Opsonic antibodies to Enterococcus faecalis strain 12030 are directed against lipoteichoic acid. Infect Immun 2006;74:5703-12
   PubMedGoogle Scholar
• Havard CW, Garrod LP, Waterworth PM. Deaf or dead? Br Med J 1959;1:688-9
   PubMedGoogle Scholar
• Fernández-Hidalgo N, Almirante B, Gavaldà J, et al. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating Enterococcus faecalis infective endocarditis. Clin Infect Dis 2013;56:1261-8
   PubMed Web of Science ®Google Scholar
• Munita JM, Arias CA, Murray BE. Editorial commentary: Enterococcus faecalis infective endocarditis: is it time to abandon aminoglycosides? Clin Infect Dis 2013;56:1269-72
   PubMed Web of Science ®Google Scholar
• Farina C, Russello G, Chinello P, et al. In vitro activity effects of twelve antibiotics alone and in association against twenty-seven Enterococcus faecalis strains isolated from Italian patients with infective endocarditis: high in vitro synergistic effect of the association ceftriaxone-fosfomycin. Chemotherapy 2011;57:426-33
   PubMed Web of Science ®Google Scholar